The Medical Management of HIV/AIDS 2013

This course provides the active, intermediate to advanced clinician, with a comprehensive review of the science of HIV and hepatitis as well as the application of HIV, HCV and HBV therapy. Lectures are presented by a group of leading clinicians and researchers who are also dedicated to teaching in their areas of expertise. In the opening plenary, Monica Gandhi, MD, will help us understand the lessons of our national epidemiology while Diane Havlir, MD will frame the conference by giving her keen take on the top 10 issues in HIV medicine, followed by Steven Deeks, MD, who will continue the exploration of the proximity to a cure.

In addition, ARV therapy will be explored with a focus on fixed drug combinations for initial and experienced patients and a lively debate will ensue over when to switch ARV's. On the final day of the course, you will be able to privately test your ARV judgment and compare it to the choices that our master clinicians make on the ARV panel.

Other topics including end organ disease (pulmonary, dermatologic, bone, HPV disease and reproductive health) as well as primary care management of HIV patients (vaccines, primary care guidelines, PrEP, transgender health, motivational interviewing and lipids) will be weaved throughout the course. Glen Treisman, MD, PhD, will give the Saturday plenary on HIV, aging and mental health.

This year, the Hepatitis session has been vastly expanded to address new options for patients co-infected with HIV and HCV and/or HBV. This session will address questions that arise in the care of chronically co-infected patients, including the safe administration of new, more efficacious therapies. A small group session will illustrate how the UCSF-SFGH Clinic helps to support co-infected patients to successfully engage and remain in treatment.

This symposium is presented by the division of HIV/AIDS, San Francisco General Hospital, Department of Medicine, University of California, San Francisco, School of Medicine.